Showing results (291-300 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|January 25, 2008
CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in AbidjanJ Duvignac, X Anglaret, A Kpozehouen, et al.HIV Clinical Trials|January 31, 2017
HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimenMaile Y Karris, Sonia Jain, Tyler R C Day, et al.HIV Clinical Trials|March 21, 2019
Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-RegistryJenny Bischoff, Stefan Mauss, Christiane Cordes, et al.HIV Clinical Trials|March 21, 2019
Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjectsAmedeo F Capetti, Giuseppe V De Socio, Maria V Cossu, et al.HIV Clinical Trials|October 30, 2018
Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare systemMichael A Horberg, Allison H Oakes, Leo B Hurley, et al.HIV Clinical Trials|March 18, 2017
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trialFrank A Post, Yazdan Yazdanpanah, Gabriel Schembri, et al.HIV Clinical Trials|November 9, 2012
Vitamin D deficiency is common among HIV-infected breastfeeding mothers in Pune, India, but is not associated with mother-to-child HIV transmissionVidya Mave, Dhananjay Shere, Nikhil Gupte, et al.HIV Clinical Trials|August 2, 2012
Bone effects of rosiglitazone in HIV-infected patients with lipoatrophyAllison C Ross, Corrilynn O Hileman, Todd T Brown, et al.HIV Clinical Trials|June 21, 2014
Factors associated with study attrition among HIV-infected risky drinkers in St. Petersburg, RussiaT Kiriazova, D M Cheng, S M Coleman, et al.HIV Clinical Trials|August 21, 2002
Randomized, placebo-controlled trial of product R, a peptide-nucleic acid immunomodulator, in the treatment of adults infected with HIVPaul N Levett, Shalom Z Hirschman, Timothy C Roach, et al.Pageof 68